全文获取类型
收费全文 | 3104篇 |
免费 | 138篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 151篇 |
妇产科学 | 94篇 |
基础医学 | 222篇 |
口腔科学 | 42篇 |
临床医学 | 354篇 |
内科学 | 687篇 |
皮肤病学 | 37篇 |
神经病学 | 124篇 |
特种医学 | 473篇 |
外科学 | 342篇 |
综合类 | 40篇 |
一般理论 | 2篇 |
预防医学 | 196篇 |
眼科学 | 35篇 |
药学 | 126篇 |
1篇 | |
中国医学 | 4篇 |
肿瘤学 | 313篇 |
出版年
2022年 | 14篇 |
2021年 | 30篇 |
2020年 | 27篇 |
2019年 | 27篇 |
2018年 | 38篇 |
2017年 | 29篇 |
2016年 | 50篇 |
2015年 | 61篇 |
2014年 | 87篇 |
2013年 | 92篇 |
2012年 | 125篇 |
2011年 | 129篇 |
2010年 | 101篇 |
2009年 | 96篇 |
2008年 | 109篇 |
2007年 | 102篇 |
2006年 | 126篇 |
2005年 | 136篇 |
2004年 | 119篇 |
2003年 | 104篇 |
2002年 | 128篇 |
2001年 | 113篇 |
2000年 | 109篇 |
1999年 | 98篇 |
1998年 | 110篇 |
1997年 | 113篇 |
1996年 | 107篇 |
1995年 | 77篇 |
1994年 | 66篇 |
1993年 | 60篇 |
1992年 | 68篇 |
1991年 | 60篇 |
1990年 | 50篇 |
1989年 | 59篇 |
1988年 | 48篇 |
1987年 | 56篇 |
1986年 | 35篇 |
1985年 | 48篇 |
1984年 | 29篇 |
1983年 | 27篇 |
1982年 | 21篇 |
1981年 | 21篇 |
1980年 | 17篇 |
1979年 | 17篇 |
1977年 | 11篇 |
1976年 | 14篇 |
1975年 | 12篇 |
1973年 | 13篇 |
1971年 | 12篇 |
1966年 | 10篇 |
排序方式: 共有3267条查询结果,搜索用时 15 毫秒
1.
C. Banella M. Ginevrino G. Catalano E. Fabiani G. Falconi M. Divona P. Curzi P. Panetta M.T. Voso N.I. Noguera 《Hematology/oncology and stem cell therapy》2021,14(2):163-168
FGFR–TACC, found in different tumor types, is characterized by the fusion of a member of fibroblast grown factor receptor (FGFR) tyrosine kinase (TK) family to a member of the transforming acidic coiled-coil (TACC) proteins. Because chromosome numerical alterations, hallmarks of FGFR–TACC fusions are present in many hematological disorders and there are no data on the prevalence, we studied a series of patients with acute myeloid leukemia and myelodysplastic syndrome who presented numerical alterations using cytogenetic traditional analysis. None of the analyzed samples showed FGFR3–TACC3 gene fusion, so screening for this mutation at diagnosis is not recommended. 相似文献
2.
PJ Commerford 《Cardiovascular journal of Africa》2015,26(4):151-Aug;26(4):151
3.
4.
Hans Bosma Martin PJ van Boxtel Gertrudis IJM Kempen Jacques ThM van Eijk Jelle Jolles 《BMC public health》2007,7(1):179
Background
The aims of this study were to examine the extent to which higher intellectual abilities protect higher socio-economic groups from functional decline and to examine whether the contribution of intellectual abilities is independent of childhood deprivation and low birth weight and other socio-economic and developmental factors in early life. 相似文献5.
G B Catalano N Cavallaro P Gangemi A Garozzo G Gorgone F Spina 《Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde》1988,196(4):200-203
A rare case of basosquamous carcinoma of the orbit invading the maxillary sinus is presented. The authors discuss clinical and pathological findings. Techniques for removal and reconstructive plastic surgery are reported. 相似文献
6.
7.
8.
Previous reports in the literature have described correlation of increasing repeat length with severity of the phenotype, in Kennedy syndrome. We describe male siblings with different repeat lengths, with lack of expression of the phenotype in the sibling with the longer repeat length. The phenotype was identical to motor neurone disease. There is variability of expression in Kennedy syndrome and repeat length even in siblings cannot be taken as a conclusive indicator of severity. CAG repeat length cannot be used to predict the natural history of Kennedy disease. The diagnosis of Kennedy syndrome should be considered in male patients presenting with atypical motor neurone disease. 相似文献
9.
PJ Woll PhD MRCP R Pettengell PhD FRACP 《International journal of clinical practice》1997,51(2):111-115
SUMMARY The interferons are natural glycoproteins secreted in response to various stimuli, including viral infection. They have antiviral, antiproliferative and immunomodulatory effects on different target cell populations. Since recombinant human interferons have become available, they have been tested in a wide range of malignancies. They are well established in the treatment of hairy cell leukaemia, chronic myelogenous leukaemia and multiple myeloma. Although they have documented activity against lymphoma, melanoma, renal cell cancer and carcinoid tumours, their role in the treatment of these tumours is less clear. In the common solid tumours, such as lung cancer and colorectal cancer, the use of interferons remains experimental. Here we will summarise their practice applications in oncology, using randomised studies where available to establish their place in multi-modality treatment. We will not discuss their use as antiviral or immunomodulating agents in viral and autoimmune diseases, multiple sclerosis or after organ transplantation. 相似文献
10.
Nancy Morabito Agostino Gaudio Antonino Lasco Antonino Catalano Marco Atteritano Aldo Trifiletti Giuseppina Anastasi Darwin Melloni Nicola Frisina 《Journal of bone and mineral research》2004,19(11):1766-1770
Today, androgen deprivation therapy is a cornerstone of treatment for advanced prostate cancer, although it presents important complications such as osteoporosis. Neridronate, a relatively new bisphosphonate, is able to prevent bone loss in patients with prostate cancer during androgen ablation. INTRODUCTION: Androgen-deprivation therapy (ADT) is a cornerstone of treatment for advanced prostate cancer. This therapy has iatrogenic complications, such as osteoporosis. The aim of our study was to evaluate the efficacy of neridronate, a relatively new bisphosphonate, to prevent bone loss during androgen ablation. MATERIALS AND METHODS: Forty-eight osteoporotic patients with prostate cancer, treated with 3-month depot triptorelina, were enrolled and randomly assigned to two different treatment groups: group A (n = 24) was treated with a daily calcium and cholecalciferol supplement (500 mg of elemental calcium and 400 IU cholecalciferol), and group B (n = 24) received in addition to the same daily calcium and cholecalciferol supplement, 25 mg of neridronate given intramuscularly every month. All patients also received bicalutamide for 4 weeks. Lumbar and femoral BMD was evaluated by DXA at baseline and after 1 year of therapy; moreover, deoxypyridinoline (DPD) and bone alkaline phosphatase (BALP) were determined at the beginning, midway through, and at the end of the study. RESULTS: After 6 and 12 months, whereas patients treated only with calcium and cholecalciferol (group A) showed a marked bone loss, with increased levels of DPD and BALP compared with baseline values, patients treated also with neridronate (group B) had substantially unchanged levels of these markers. After 1 year of treatment, lumbar and total hip BMD decreased significantly in patients treated only with calcium and cholecalciferol (group A), whereas it did not change significantly at any skeletal site in patients treated also with neridronate (group B). No relevant side effects were recorded during our study. CONCLUSIONS: Neridronate is an effective treatment in preventing bone loss in the hip and lumbar spine in men receiving ADT for prostate cancer. 相似文献